An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of hydroxychloroquine and chloroquine therapy.


Creative Commons License

Celotto S., Veronese N., Barbagallo M., Ometto F., Smith L., Pardhan S., ...Daha Fazla

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, cilt.103, ss.599-606, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

Özet

BACKGROUND & AIMS: Hydroxychloroquine (HCQ) and chloroquine (CQ) are anti-malarial drugs frequently used in the rheumatologic field. They were recently identified as potential therapeutic options for Coronavirus Disease (COVID-19). The present study aims to map and grade the diverse health outcomes associated with HCQ/CQ using an umbrella review approach.